Drugs.com - Pharma Industry News

Monthly News Roundup - April 2025

FDA Approves FcRn Blocker Imaavy for the Treatment of Generalized Myasthenia Gravis The United States Food and Drug Administration (FDA) has approved Johnson & Johnson’s Imaavy (nipocalimab-aahu) as the first and only neonatal Fc...

May 5, 2025 - 04:28
 0
Monthly News Roundup - April 2025
FDA Approves FcRn Blocker Imaavy for the Treatment of Generalized Myasthenia Gravis The United States Food and Drug Administration (FDA) has approved Johnson & Johnson’s Imaavy (nipocalimab-aahu) as the first and only neonatal Fc...
Read More

Tags:

Previous Article

Saturn swamped with cash

Next Article

Turaco to examine West African development with bolstered resource now in hand

Related Posts

Study IDs Predictors of Biomechanical Function in Patients With OA Undergoing Hip Replacement

Study IDs Predictors of Biomechanical Function in Patie...

Apr 23, 2025  0

Air, Light Pollution May Increase Risk for Pediatric Papillary Thyroid Cancer

Air, Light Pollution May Increase Risk for Pediatric Pa...

Apr 22, 2025  0

Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis

Brensocatib Leads to Lower Rate of Pulmonary Exacerbati...

Apr 24, 2025  0